// App-Quantinova.ai

3573 : Evaluation of Healthcare Resource Utilization and Costs Among Patients with Chronic Myeloid Leukemia after Disease Progression

Researchers

Presenter

  • Elias Jabbour

Principal Investigators

  • Jay Lin

  • Lisa R Siegartel

  • Melissa Lingohr-Smith

  • Brandy Menges

  • Dinara Makenbaeva

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Novosys Health, Green Brook, NJ

Locations

  • United States

Companies

  • Bristol-Myers Squibb

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Chronic Myelogenous Leukemia

  • Acute myelocytic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim